https://orcid.org/0000-0002-6283-7549
References
- Moscarelli L, Annunziata F, Mjeshtri A, et al. Successful treatment of refractory wart with a topical activated vitamin D in a renal transplant recipient. Case Rep Transplant. 2011;2011:1–3.
- Rind T, Oiso N, Kawada A. Successful treatment of anogenital wart with a topical vitamin D (3) derivative in an infant. Case Rep Dermatol. 2010;2(1):46–49.
- Aktaş H, Ergin C, Demir B, et al. Intralesional vitamin D injection may be an effective treatment option for warts. J Cutan Med Surg. 2016;20(2):118–122.
- El-Taweel AE, Salem RM, Allam AH. Cigarette smoking reduces the efficacy of intralesional vitamin D in the treatment of warts. Dermatol Ther. 2019;32(2):e12816.
- Raghukumar S, Ravikumar BC, Vinay KN, et al. Intralesional vitamin D3 injection in the treatment of recalcitrant warts: a novel proposition. J Cutan Med Surg. 2017;21(4):320–324.
- Murakami S, Mealey BL, Mariotti A, et al. Dental plaque‐induced gingival conditions. J Periodontol. 2018;89(1):S17–S27.
- Duplantier A, van Hoek M. The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds. Front Immunol. 2013;3(4):143.
- Alikhan A, Griffin JR, Newman CC. Use of Candida antigen injections for the treatment of verruca vulgaris: a two‐year mayo clinic experience. J Dermatolog Treat. 2016;27(4):355–358.
- Abou-Taleb DAE, Abou-Taleb HA, El-Badawy O, et al. Intralesional vitamin D3 versus intralesional purified protein derivative in treatment of multiple warts: a comparative clinical and immunological study. Dermatol Ther. 2019;32(5):e13034.
- Kareem IMA, Ibrahim IM, Mohammed SFF, et al. Effectiveness of intralesional vitamin D3 injection in the treatment of common warts: single-blinded placebo-controlled study. Dermatol Ther. 2019;32(3):e12882.
- Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001;137(4):451–455.
- Uh ST, Koo SM, Kim YK, et al. Inhibition of vitamin d receptor translocation by cigarette smoking extracts. Tuberc Respir Dis. 2012;73(5):258–265.
- Kavya M, Shashikumar BM, Harish MR, et al. Safety and efficacy of intralesional vitamin D3 in cutaneous warts: an open uncontrolled trial. J Cutan Aesthet Surg. 2017;10(2):90–94.
- Abd El-Magid WM, Nada EEA, Mossa RA. Intralesional injection of vitamin D3 versus zinc sulfate 2% in treatment of plantar warts: a comparative study. J Dermatolog Treat. 2019:1–6. [Epup ahead of print].
- Gracie J, Baker C, Freeston MH, et al. The role of psychological factors in the aetiology and treatment of vasovagal syncope. Indian Pacing Electrophysiol J. 2004;4(2):79–84.
- Conner K, Nern K, Rudisill J, et al. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J Am Acad Dermatol. 2002;47(3):347–350.
- Kim JE, Kim HJ, Choi JM, et al. The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma. Br J Dermatol. 2010;163(5):959–967.
- Schögler A, Stokes AB, Casaulta C, et al. Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection. J Cyst Fibros. 2016;15(3):332–339.
- Park J, Shrestha R, Qiu C, et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science. 2018;360(6390):758–763.
- Sharifi A, Hosseinzadeh-Attar MJ, Vahedi H, et al. A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients. Saudi J Gastroenterol. 2016;22(4):316–323.
- Gwyer Findlay E, Currie SM, Davidson DJ. Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs. 2013;27(5):479–493.
- Di Nardo A, Braff MH, Taylor KR, et al. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J Immunol. 2007;178(3):1829–1834.
- Tokumaru S, Sayama K, Shirakata Y, et al. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol. 2005;175(7):4662–4668.
- Koczulla R, von Degenfeld G, Kupatt C, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111(11):1665–1672.
- Braff MH, Hawkins MA, Di Nardo A, et al. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol. 2005;174(7):4271–4278.